Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities - PubMed (original) (raw)

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities

R A Koup et al. J Exp Med. 1991.

Abstract

The presence of cytotoxic T lymphocytes (CTL) to the gag antigens of human immunodeficiency virus (HIV) has been described in infected populations. We found that the majority of this immune response as measured in bulk CTL assays of unstimulated peripheral blood mononuclear cells (PBMC) is directed against the p24 component of the p55 gag precursor protein. Using limiting dilution analysis of this effector cell population we confirm that the majority of activated gag-specific CTL circulating in the PBMC of infected hemophilic patients are directed at p24 determinants and are present at frequencies of 1/36,000 to 1/86,000 lymphocytes. By performing in vitro stimulation after limiting dilution, the precursor population of gag-specific CTL are characterized and quantitated. HIV gag-specific CTL precursors are identified at frequencies of 1/1700 to 1/17,000 lymphocytes and are made up of cells with both p17 and p24 specificities. No HIV gag-specific CTL precursor cells are identified in the PBMC of HIV-uninfected individuals. These studies demonstrate that CTL directed at both p17 and p24 determinants make up the cellular immune repertoire in HIV-infected individuals but that only the p24-specific CTL are routinely found in an activated state in the circulation.

PubMed Disclaimer

Cited by

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.
Kalams SA, Buchbinder SP, Rosenberg ES, Billingsley JM, Colbert DS, Jones NG, Shea AK, Trocha AK, Walker BD. Kalams SA, et al. J Virol. 1999 Aug;73(8):6715-20. doi: 10.1128/JVI.73.8.6715-6720.1999. J Virol. 1999. PMID: 10400769 Free PMC article.
High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. Elovaara I, et al. J Exp Med. 1993 Jun 1;177(6):1567-73. doi: 10.1084/jem.177.6.1567. J Exp Med. 1993. PMID: 8496677 Free PMC article.
Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.
Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'Aquila RT, Kurnick JT, Walker BD. Kalams SA, et al. J Exp Med. 1994 Apr 1;179(4):1261-71. doi: 10.1084/jem.179.4.1261. J Exp Med. 1994. PMID: 8145043 Free PMC article.
Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants.
Pikora CA, Sullivan JL, Panicali D, Luzuriaga K. Pikora CA, et al. J Exp Med. 1997 Apr 7;185(7):1153-61. doi: 10.1084/jem.185.7.1153. J Exp Med. 1997. PMID: 9104802 Free PMC article.

References

1. Int Immunol. 1990;2(8):707-12 - PubMed
1. J Immunol. 1981 Aug;127(2):487-91 - PubMed
1. J Virol. 1989 Feb;63(2):584-90 - PubMed
1. J Pediatr. 1986 Apr;108(4):504-10 - PubMed
1. J Clin Invest. 1985 Oct;76(4):1699-704 - PubMed

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities - PubMed (original) (raw)